Rational Drug Repurposing: Focus on Lysosomotropism, Targets in Disease Process, Drug Profile, and Pulmonary Tissue Accumulation in SARS-CoV-2 Infection/COVID-19
Download full text files
Additional Services
Statistics
| Author: | Markus Blaess, Lars Kaiser, Oliver Sommerfeld, Simone Rentschler, René Csuk, Hans-Peter DeignerORCiDGND |
|---|---|
| URN: | https://urn:nbn:de:bsz:fn1-opus4-68639 |
| DOI: | https://doi.org/10.3389/fphar.2020.584881 |
| ISSN: | 1663-9812 |
| Parent Title (English): | Frontiers in Pharmacology |
| Document Type: | Article (peer-reviewed) |
| Language: | English |
| Year of Completion: | 2020 |
| Release Date: | 2020/12/22 |
| Tag: | Approved active compounds; COVID-19; Cytokine storm syndrome; Lysosome; Lysosomotropic compounds; Lysosomotropism; Repurposing approved drugs; SARS-CoV-2 |
| Volume: | 11.2020 |
| Issue: | November Article 584881 |
| Page Number: | 6 |
| Open-Access-Status: | Open Access |
| Licence (German): |  Creative Commons - CC BY - Namensnennung 4.0 International |